Clinical Trials Directory

Trials / Completed

CompletedNCT00015301

Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11

Methylphenidate Raclopride PET Test

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
0 (planned)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate PET methodology to study in vivo synaptic dopamine release.

Detailed description

The objective of this study is to evaluate PET methodology to study in vivo synaptic dopamine release.

Conditions

Interventions

TypeNameDescription
DRUGMethylphenidate

Timeline

Start date
2003-12-01
Primary completion
2005-06-01
Completion
2005-08-01
First posted
2001-04-18
Last updated
2017-02-24

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT00015301. Inclusion in this directory is not an endorsement.

Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11 (NCT00015301) · Clinical Trials Directory